Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.
about
Therapeutic efficacy of nanomedicines for prostate cancer: An updateUpconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathway.Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.
P2860
Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@ast
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@en
type
label
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@ast
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@en
prefLabel
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@ast
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@en
P2860
P921
P356
P1476
Poly(styrene)-b-poly(DL-lactid ...... for anticancer drug delivery.
@en
P2093
Dae-Duk Kim
Jung Sun Kim
P2860
P304
P356
10.2147/IJN.S62806
P407
P577
2014-06-03T00:00:00Z